|
Xenova Group (LSE: XEN.L - news) (XEN) improved 3.5p to 99.5p on whispers that the biotech could emerge with good news on its anti-cancer treatment, which allows the repeated use of chemotherapy. That drug, XR9576, has been successfully tested in combination with a chemotherapy treatment from Schering-Plough of the US. |
|
| aus der Diskussion: | XENOVA - DISKUSSIONS-THREAD Nr. 2 (Stand: 06.11.2000) |
| Autor (Datum des Eintrages): | Panospana (30.01.01 23:21:43) |
| Beitrag: | 29 von 275 (ID:2807063) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |